June 11, 2020 / 12:47 PM / a month ago

BRIEF-Cellectar To Be Granted EU Patent For Phospholipid Ether Analogs As Cancer-Targeting Drug Vehicles

June 11 (Reuters) - Cellectar Biosciences Inc:

* CELLECTAR TO BE GRANTED EU PATENT FOR PHOSPHOLIPID ETHER (PLE) ANALOGS AS CANCER-TARGETING DRUG VEHICLES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below